LAS VEGAS – The Rx Assistant has launched Builder, a no-code artificial intelligence platform that helps pharmaceutical companies develop and deploy digital experiences for patients and health care professionals across multiple communication channels.
The platform, unveiled Tuesday at HLTH 2026, enables pharmaceutical brands to build AI-powered tools for patient engagement, treatment navigation, affordability assistance, and reimbursement support via voice, text messaging, email, and online chat.
Builder combines conversational AI, regulatory review workflows, and analytics into a single system. The platform also integrates with existing patient support programs, pharmacy systems, electronic medical records, and customer relationship management platforms.
According to the company, early deployments have progressed from contract signing to regulatory approval in as little as eight weeks. Among existing deployments, 75% of engaged users completed a high-value action, such as finding a doctor or completing a symptom assessment. The company also reported that its AI concierge generated more than three times as many high-value actions as the pharmaceutical brands’ websites.
“A brand’s website has become a key part of the patient journey,” said Jake Coniglio, co-founder and CEO of The Rx Assistant. “When a patient uses a chat, a quiz or a doctor finder, they’re telling you they need help or are ready to take action.”
The platform includes automated adverse event logging and reporting, along with tools to support pharmaceutical regulatory review requirements. It also enables companies to track performance using metrics such as prescription fill rates, time to therapy, and medication adherence.
The launch comes as patients increasingly seek information about specific treatments before visiting health care providers. According to the ZS Impact Institute’s 2026 Future of Health report, 52% of U.S. patients request specific medications, and 68% of providers report more patients asking for treatments by name.
The Rx Assistant also received the Rising Star award in the Therapeutics, Pharmacy & Medication Innovation category at the Digital Health Hub Foundation’s 2026 Digital Health & AI Awards, selected from more than 1,300 submissions.
Founded by former executives from GoodRx, One Medical, and Epocrates, the company is backed by GoodRx and Suncoast Ventures.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release